Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr14 Inhibitors

Olr14 inhibitors are a distinct class of chemical compounds designed to target and inhibit the function of the Olr14 receptor, an olfactory receptor that is part of the G protein-coupled receptor (GPCR) superfamily. These receptors are integral to the olfactory system, where they play a key role in detecting odorant molecules and initiating the signaling processes that lead to the perception of smell. Olr14 inhibitors function by binding to specific sites on the receptor, such as the active site where natural odorant molecules would typically bind, or by interacting with allosteric sites that modulate the receptor's activity. This binding effectively blocks the receptor from undergoing the conformational changes necessary to activate intracellular signaling pathways. By inhibiting these processes, Olr14 inhibitors prevent the transmission of olfactory signals, thereby disrupting the receptor's normal role in the sensory processing of smells. The development of Olr14 inhibitors often involves detailed structural studies of the receptor, using advanced techniques such as X-ray crystallography, molecular dynamics simulations, and cryo-electron microscopy. These techniques provide essential insights into the receptor's binding pockets and other structural features, enabling the design of inhibitors that are highly specific to the Olr14 receptor and effective in modulating its activity.

Chemically, Olr14 inhibitors exhibit a wide range of molecular structures, reflecting the diverse synthetic strategies employed in their design and development. These inhibitors can vary from small, lipophilic molecules that easily cross cellular membranes to reach their target receptors, to larger, more complex molecules that may require advanced synthetic methods to achieve the desired binding affinity and specificity. The synthesis of Olr14 inhibitors typically involves multiple steps of organic chemistry, including the construction of molecular frameworks and the incorporation of functional groups that enhance the compound's interaction with the receptor. Once synthesized, these inhibitors undergo rigorous characterization using a variety of analytical techniques, such as nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry, and high-performance liquid chromatography (HPLC). These methods are used to ensure the structural integrity, purity, and inhibitory potency of the compounds. The study of Olr14 inhibitors is crucial for advancing our understanding of the specific mechanisms by which this olfactory receptor functions and how its activity can be modulated by small molecules. Additionally, this research contributes to the broader field of GPCR biology, offering valuable insights into the molecular processes underlying sensory perception, particularly within the context of olfaction. By deepening our knowledge of how olfactory receptors function and how they can be selectively targeted, scientists can explore new directions in the study of sensory systems and the complex biochemical pathways that govern them.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Acarbose

56180-94-0sc-203492
sc-203492A
1 g
5 g
$226.00
$605.00
1
(1)

Alpha-glucosidase inhibitor, may indirectly influence GPCR signaling via modulation of glucose metabolism, impacting Olr14.

(RS)-Atenolol

29122-68-7sc-204895
sc-204895A
1 g
10 g
$79.00
$416.00
1
(1)

Beta-1 adrenergic receptor antagonist, can modulate GPCR signaling pathways, potentially impacting Olr14.

Diltiazem

42399-41-7sc-204726
sc-204726A
1 g
5 g
$209.00
$464.00
4
(1)

Calcium channel blocker, might alter GPCR signaling by influencing calcium ion dynamics, impacting Olr14.

Ezetimibe

163222-33-1sc-205690
sc-205690A
25 mg
100 mg
$96.00
$241.00
12
(2)

Cholesterol absorption inhibitor, can influence GPCR signaling indirectly through lipid metabolism pathways, impacting Olr14.

Fexofenadine

83799-24-0sc-218475
100 mg
$298.00
1
(0)

Antihistamine, may modulate GPCR signaling indirectly, affecting Olr14.

Losartan

114798-26-4sc-353662
100 mg
$130.00
18
(1)

Angiotensin II receptor antagonist, can modulate GPCR signaling indirectly, potentially impacting Olr14.

Nifedipine

21829-25-4sc-3589
sc-3589A
1 g
5 g
$59.00
$173.00
15
(1)

Calcium channel blocker, might affect GPCR signaling through calcium modulation, impacting Olr14.

Ramipril

87333-19-5sc-205833
sc-205833A
sc-205833B
sc-205833C
sc-205833D
500 mg
1 g
2 g
5 g
10 g
$179.00
$245.00
$364.00
$733.00
$1254.00
1
(1)

ACE inhibitor, could indirectly modulate GPCR signaling pathways, potentially affecting Olr14.

Simvastatin

79902-63-9sc-200829
sc-200829A
sc-200829B
sc-200829C
50 mg
250 mg
1 g
5 g
$31.00
$89.00
$135.00
$443.00
13
(1)

HMG-CoA reductase inhibitor, may influence GPCR signaling indirectly through cholesterol biosynthesis pathways, impacting Olr14.

Vardenafil

224785-90-4sc-362054
sc-362054A
sc-362054B
100 mg
1 g
50 g
$526.00
$735.00
$16653.00
7
(1)

Phosphodiesterase-5 inhibitor, can indirectly affect GPCR signaling through modulation of cyclic GMP levels, impacting Olr14.